Flagstone Financial Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Hold
1,737
0.05% 74
2026
Q1
$242K Buy
+1,737
New +$243K 0.06% 64

Other funds holding GILD

Flagstone Financial Management's GILD Position: Q2 2026 in Review

Flagstone Financial Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,737 shares worth $219K. The position accounts for 0.05% of the portfolio, ranked #74.

Flagstone Financial Management first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $242K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Flagstone Financial Management held 1,737 shares of Gilead Sciences worth $219K as of Q2 2026.
  • Flagstone Financial Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.05% of Flagstone Financial Management's portfolio in Q2 2026, its #74 holding.
  • Flagstone Financial Management first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Flagstone Financial Management's Gilead Sciences position peaked at $242K in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Flagstone Financial Management's 13F filing for Q2 2026, filed 21 Jul 2026.